People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vibliome Therapeutics, Llc | — | Pharma | Series A | $8.0M | $247.8M | 2019 |
| Vibliome Therapeutics, Inc. | — | Pharma | Pre-Seed | $113K | $5.3M | 2018 |
GARY FLYNN at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside GARY FLYNN on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Goodwin | 2 | 3 |
| Cameron Wheeler | 1 | 9 |
| MICHAEL FARRELL | 1 | 6 |
| Bryan Sendrowski | 1 | 3 |
| ROBERT JACKSON | 1 | 3 |
| Jonathan Ramos | 1 | 2 |
| JAMES LINFIELD | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.